Biomarker Profiling in Individuals at Risk for Prion Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Biomarker Profiling in Individuals at Risk for Prion Disease — Stella

Recruiting

Back to CJD (Creutzfeldt Jakob Disease) trials

Trial locations(1 site)

United States

Alzheimer's Clinical and Translational Research Unit, Charlestown, Massachusetts

Key details

Sponsor

Massachusetts General Hospital

Collaborators

Broad Institute of MIT and Harvard

Enrollment target

~150 participants

Started

December 2017

Primary completion

June 2027

Age range

18 Years – 85 Years

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov